Tessa Thompson and Jon Bernthal have dazzled audiences in big-budget MCU titles like Thor: Ragnarok and Punisher, as well as ...
Zacks Investment Research on MSN
Hims & Hers expands weight-management program to the United Kingdom
Hims & Hers HIMS recently announced that it is expanding access to its comprehensive Weight Loss Program to customers in the ...
The trajectory of well-known health and wellness platform Hims & Hers is one that most entrepreneurs and investors would hope for. Not even six years old, the company has for the most part experienced ...
Hims & Hers Health announced on Tuesday it will bundle Wegovy with the telehealth platform’s membership through a new collaboration with drugmaker Novo Nordisk. The bundle will offer Novo Nordisk’s ...
Zacks Investment Research on MSN
Hims & Hers expands its technology-driven personalized virtual care
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates as a deeply technology-driven digital ...
The market is just starting to notice the great things this small-cap stock has been doing for a while now. It often feels like you've missed the boat when you sit there reading about another stock ...
The move into the UK weight-loss category has been facilitated by the acquisition earlier this year of Zava, a London-based ...
Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make its weight loss drug Wegovy available on the telehealth company's platform ...
Eli Lilly and Co (NYSE:LLY) today announced an expansion in the availability of its obesity treatment, Zepbound (tirzepatide), which is now offered in 2.5 mg and 5 mg single-dose vials at a discounted ...
Online health and wellness company Hims & Hers bumped its full-year revenue forecast higher following strong growth in subscribers and double-digit net income in the first quarter. The company, which ...
Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its way into Europe and wants to build more personalized drugs for its telehealth ...
Health platform Hims & Hers Health Inc. announced Monday that it's rolling out injectable weight-loss drugs that cost a fraction of the price of competitors Wegovy and Ozempic. Hims & Hers says its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results